WASHINGTON — The U.S. Defense Department is getting set to push for a new vaccine against “Q-fever” bacteria, an agent with a reputation as a potential terrorism tool acquired in part through its history as a government-made biological weapon.
The Pentagon’s Defense Threat Reduction Agency is planning an online forum on Dec. 5 to facilitate conversation with potential developers of a vaccine against Q fever, which is also known by the bacteria’s formal designation, Coxiella burnetii.
The United States investigated the agent’s warfare potential and the Soviet Union fully weaponized it decades ago, long before both countries formally denounced biological arms in the 1970s. The disease also occurs in nature and has affected hundreds of U.S. troops deployed overseas.
It can produce fever, pneumonia, and numerous other symptoms associated with a variety of pathogens.
Certain antibiotics are considered effective against the bacteria, but no vaccine is presently sold in the United States, according to the Federation of American Scientists. An existing vaccination available abroad reportedly can cause side effects such as abscesses and swollen joints.
The United States “should definitely have a Q fever vaccine,” Amesh Adalja, a senior associate with the Center for Health Security at the University of Pittsburgh Medical Center, said in a phone interview. “This is still a disease that has some public health burden, in addition to its potential use as a bioweapon.”
The U.S.-led occupation of Iraq led to roughly 200 “acute” Q-fever cases among U.S. soldiers, the Centers for Disease Control and Prevention reported earlier this year.
Those infections appeared to result from unintentional exposure to animal carriers or bacteria swept up by helicopter rotors. Such naturally occurring cases rarely cause death, but Adalja suggested the agent could prove more dangerous if incorporated in a weapon.
Q-Fever bacteria infected but reportedly did not kill any conscientious war objectors deliberately exposed to the agent during U.S. Army experiments in the 1950s.
The United States has been eyeing a new Q-fever vaccine for several years. However, the agent’s status as a potential bioterrorism tool is fairly new, relative to how long it has been an established biological weapon. CDC officials only began tracking Q-fever infections in 1999, as the Clinton administration was increasing the nation’s focus on biological terrorism as a national-security threat.
A CDC list of potential bioterrorism agents and diseases, which includes Q fever, “is derived almost solely from the U.S. and Soviet bioweapons programs,” Adalja said. He suggested that the U.S. government is “substantially” more likely to fund development of vaccines and treatments for such agents than for pathogens never involved in government biological-weapons programs.
Agents more than dangerous than Q-fever may have emerged since the Cold-War height of the U.S. and Soviet biological-weapons programs, but the established track record of historical biological arms could make them particularly attractive to would-be bioterrorists, Adalja said.
This article was published in Global Security Newswire, which is produced independently by National Journal Group under contract with the Nuclear Threat Initiative. NTI is a nonprofit, nonpartisan group working to reduce global threats from nuclear, biological, and chemical weapons.
What We're Following See More »
The Signal app is fast becoming the new favorite among those who are obsessed with the security and untraceabilty of their messaging. Just ask the Democratic National Committee. Or Edward Snowden. As Vanity Fair reports, before news ever broke that the DNC's servers had been hacked, word went out among the organization that the word "Trump" should never be used in their emails, lest it attract hackers' attention. Not long after, all Trump-related messages, especially disparaging ones, would need to be encrypted via the Snowden-approved Signal.
The Republican Study Committee may lose several members of the House Freedom Caucus next year, "potentially creating a split between two influential groups of House conservatives." The Freedom Caucus was founded at the inception of the current Congress by members who felt that the conservative RSC had gotten too cozy with leadership, "and its roughly 40 members have long clashed with the RSC over what tactics to use when pushing for conservative legislation." As many as 20 members may not join the RSC for the new Congress next year.
"The U.S. Food and Drug Administration on Monday issued emergency authorization for a Zika diagnostics test from Swiss drugmaker Roche, skirting normal approval channels as the regulator moves to fight the disease's spread." Meanwhile, the Wall Street Journal reports that a new study in Nature identifies "about a dozen substances" that could "suppress the pathogen's replication." Some of them are already in clinical trials.
According to 37 newly released audits, "some private Medicare plans overcharged the government for the majority of elderly patients they treated." A number of Medicare Advantage plans overstated "the severity of medical conditions like diabetes and depression." The money has since been paid back, though some plans are appealing the federal audits.
"GOP leaders and House Democrats are already laying the groundwork for a short-term continuing resolution" on the budget this fall "that will set up a vote on a catch-all spending bill right before the holidays." As usual, however, the House Freedom Caucus may throw a wrench in Speaker Paul Ryan's gears. The conservative bloc doesn't appear willing to accept any CR that doesn't fund the government into 2017.